Neonate: The Neonatologist's Perspective "Preterm newborns: How imaging contributes to the understanding of the preterm infants neurodevelopmental outcome"
Petra Hüppi

Synopsis

This educational presentation will summarize the imaging tools to study the brain of preterm infants, detect brain injury and predict neurodevelopment outcome

Introduction

Neurodevelopmental disabilities observed in preterm infants encompass a wide spectrum of deficits, ranging from motor and cognitive deficits, to behavioral and psychological problems.These morbidities have important public health, economic, societal implications worldwide. In order to best target interventions to prevent and/or treat these adverse neurodevelopmental sequelae in those at risk and most vulnerable, clinicians must be able to better identify high-risk preterm infants and better prognosticate neurodevelopmental outcomes using the clinical tools available. There have been significant advances in MRI technology, but even with improvements in the field of neuroimaging with MR, there have been many challenges to its use in the neonatal population. Some of the practical barriers to its use in the neonatal population have been cost of MRI, equipment compatibility with the magnet, perception of the need for sedation, as well as general accessibility issues when compared to bedside cUS, including transport to MRI and the overall stability of critically ill neonates to leave the neonatal intensive care unit. However, with the development of MR-compatible incubators, imaging of the more critical neonates can be done in a safe, thermo-regulated, and appropriate environment with continuous cardiorespiratory monitoring. This presentation addresses the role of magnetic resonance (MR) imaging (MRI) in the prediction of neurodevelopmental outcomes in preterm infants and explores the usefulness of state-of-the-art MR strategies to better understand the preterm infants encephalopathy.

MRI and Neurodevelopmental Outcomes

Although it has been shown that MRI provides more comprehensive information of the neonatal brain structure, including more subtle abnormalities unable to be detected on cUS, the clinical implications of these findings require standardization, validation and long term follow-up. There have been numerous studies that have evaluated the ability of MRI at term equivalent age to predict neurodevelopmental outcomes at 12 months to 9 years. The studies with more recent cohorts, large sample sizes and quantitative predictive data are summarized in Table 2.

White Matter Abnormalities

The most extensively studied MRI abnormality shown to predict neurodevelopmental outcomes is white matter lesions. Types of white matter abnormalities have included periventricular leukomalacia, punctate white matter lesions (PWML), and Diffuse Excessive High Signal Intensities (DEHSI). The etiology of these entities has yet to be completely understood. Specifically in regards to PVL and PWML, it is unclear if they represent a spectrum of one disorder or separate entities with different etiologies, but they both correlate with long-term neurodevelopmental outcomes. In contrast, DEHSI has been shown in numerous studies to not correlate with long-term outcomes.2 Periventricular leukomalacia is a form of white matter injury, which is focal and cystic. It is histologically characterized by coagulative necrosis within the subventricular lamina of the periventricular white matter, leading to the destruction of cellular elements and the formation of cysts, and possibly secondary ventriculomegaly Punctate white matter lesions are non-specific focal lesions in the white matter on MRI that are also commonly found in preterm infants. They are represented as increased signal on T1-weighted imaging and decreased signal on T2-weighted imaging and may histologically reflect petechial hemorrhages, gliotic scarring, or mineralization. Diffuse excessive high signal intensities (DEHSI) are a frequent finding on T2-weighted MR images near-term in children born prematurely3 – seen in up to 80% of preterm infants at term equivalent age.4,5 They are hyperintense white matter signal abnormalities found in the periventricular and subcortical white matter regions when compared to the signal intensity of normal unmyelinated white matter. The most common outcome measure in studies that look to correlate MRI findings and neurodevelopment outcomes is motor dysfunction, ranging from mild motor delay to severe cerebral palsy. Although the ability of MRI to predict cerebral palsy can be variable, one of the most important observations from past studies is that preterm children without white matter abnormalities on term MRI did not show significant neurodevelopmental deficits compared to full term controls – specifically in regards to motor 6 cognitif and executive functioning 7,8 demonstrating that MRI has a high negative predictive value. Compared to infants born at term, preterm infants though have been shown to have cognitive impairments, requiring special assistance at school. White matter abnormalities have been shown in studies to be associated with lower cognition, language abilities, and executive functioning.

Gray Matter Abnormalities

Gray matter can be assessed for both morphology, including cortical folding and surface area, as well as signal abnormalities. Gray matter abnormalities (assessed by size of the subarachnoid space, quality of gyral maturation and presence of gray matter cortical signal abnormality) are also associated with poorer neurodevelopment outcome.

Cerebellar Abnormalities

Cerebellar abnormalities have been described as destructive lesions vs. those representing impaired development. Destructive lesions include cerebellar hemorrhage and infarction. Cerebellar hemorrhage is usually unilateral and associated with supratentorial lesions, leading to possible cerebellar atrophy with time 9 which is related to neurodevelopmental sequelae.33

Classification of qualitative MRI in the preterm infant

There have been different classification systems proposed and used for the interpretation of MRI data defining MR abnormalities and relate them to neurodevelopmental outcome (refer to Table 3) Woodward et al described and used a comprehensive scoring system to define brain abnormalities in preterm infants near term age ..11,12 A separate scoring system was used to define the extent of gray matter (GM) injuries. Moderate-to-severe cerebral white-matter abnormalities were predictive of cognitive delay with odds ratio (OR) of 3.6, motor delay with an OR of 10.3, and CP with an OR of 9.6. The OR of gray matter abnormalities in association with severe cognitive delay or CP ranged from 2-3.11 This scoring system has been further refined by Kidikoro et al.13{These scoring systems offer a more objective and comprehensive method to classify magnitude of brain injury in the preterm population given the wide range of complex MRI abnormalities associated with prematurity, as well as predict neurodevelopmental outcomes. In recent neuroprotective drug trials these methods have helped to monitor drug intervention effects 14

Timing of MRI

Both qualitative and quantitative MR techniques have been used to assess the preterm brain at different stages in development, including in the perinatal period, at term equivalent age, and through childhood into adolescence. Compared to the MRI at time of birth, the MRI at term equivalent age still remains the optimal scanning time for children born prematurely in the prediction of neurodevelopmental outcomes, given the greater clinical stability of the population at term as well as the success of feed and wrap protocols in obviating the need for sedation. In addition, the most commonly studied timing of MRI scans in the preterm population to predict neurodevelopmental outcomes is term equivalent age. However, there have been some studies investigating the correlation between serial MR imaging and neurodevelopmental outcomes, looking at changes in findings over time.

PROMISING NEW MRI STRATEGIES

The development of sophisticated new MRI strategies has permitted a better understanding of corticogenesis in the prematurely born. Furthermore, data from many of these strategies, including volumetric imaging, diffusion tensor imaging, MRS and functional connectivity, has been shown to correlate with cognitive measures in preterm subjects at school age, adolescence and young adulthood. Below we describe these strategies, and the published neonatal outcome data available. Although these studies do not represent the predictive utility of volumetric MRI in terms of PPV/NPV or sensitivity/specificity, the outcome data generated from each is presented in Table 4.

Volumetric Imaging

Volumetric analysis uses two or three-dimensional MR images to quantitatively characterize alterations of brain development associated with prematurity and brain injury. It allows for the measurement of volume of specific brain structures including the cortical and subcortical regions, cerebellum and hippocampus. Automated segmentation techniques can be used to differentiate grey matter and white matter as well as unmyelinated and myelinated tissue.15 Volume reduction in the whole brain, anatomic structures in the brain, and regionally within white matter and cortical grey matter have been reported in preterm infantsIn addition, simple brain metric measurements using MRI as a method to assess brain growth and atrophy in the neonates has been shown to correlate with outcome Smaller brain volume at term equivalent age, when correcting for effects of white matter injury, is correlated with subsequent performance on object working memory tasks in infancy.16 Subsequent working memory performance in infancy was also shown to be associated with reductions in volumes of dorsolateral prefrontal, sensory, motor, parieto-occipital and premotor cortex.16 Total white matter volumes in sensory, motor and mid-temporal regions at term equivalent age are strong predictors of neurodevelopmental outcome in the first year of life.17 Inder et al18 showed that the overall gray matter volume at term is predictive of neurodevelopmental outcome, while Boardman showed association between decreased volumes of deep gray matter and neurocognitive outcome.19

Diffusion Tensor Imaging

Assessing the microstructural development of the white and gray matter in prematurely born infants has become feasible with the recent advantages in diffusion imaging. Inferring information about the underlying tissue microstructure from dMRI is an inverse problem, were models of different complexity are fitted to the acquired signal . The most popular model to describe changes in the dMRI signal intensities is the diffusion tensor model (DTI). In this model, the directional motion of water behavior is characterized by a 3 dimensional tensor. Diffusion tensor imaging measures relies on the water motion providing the useful parameters for describing the underlying microstructure. Measure of fractional anisotropy (FA) describes the degree to which water diffusion is restricted in one direction relative to all others. FA values of major white matter tracts were correlated with gross and fine motor performance. Lower FA in regions of corpus callosum, at term equivalent age, was shown to correlate with the psychomotor developmental index Furthermore, the lower values of FA at term in posterior limb of internal capsule were associated with neurodevelopmental outcomes in first year of life. Follow-up of children with abnormal neurological exams in the first year of life showed decreased FA values in posterior limb of the internal capsule at term age when measured retrospectively. In recent years DTI has been extended to use multiple gradient directions to assess better the directionality of water diffusion in crossing fibers and multiple b-values to assess diffusion characteristics in tissue compartments defined by biophysical models such as NODDI

fMRI Functional MRI uses deoxygenated hemoglobin in the body as an endogenous contrast agent to produce a BOLD (blood-oxygenation-level-dependent) signal. This signal detects regional changes in hemodynamics of the brain that are correlated with functional activity. By utilizing these BOLD signals in neonates, it is possible to identify networks with synchronous neuronal activity in sleeping neonates to study resting state functional connectivity throughout development. Born et al was the first to use fMRI to show brain activation using visual stimulation in healthy newborns 22 and since then multiple studies have investigated the correlation between passive functions with fMRI as a clinical tool to evaluate the sensorimotor, visual and auditory systems in infants with brain injury. 23 The prognostic implications of these findings have still yet to be determined and further research in the use of functional MRI in the preterm population may contribute to the predictive abilities of long-term neurodevelopmental outcomes in the preterm population. MRS Magnetic resonance spectroscopy (MRS) is a noninvasive measure of brain biochemistry. MRS provides information regarding provides information about common metabolites found in the brain such as N-acetyl-aspartate (NAA), choline-containing compounds (Cho), creatine and lactate which are involved in cellular metabolic pathways. NAA is present in axons and considered to be a marker for neurons. It has been found to increase with advancing gestational age and maturity.24 Choline containing compounds are involved in ATP synthesis. Creatine is thought to be related to membrane metabolism. Lactate, though may be a marker for impaired metabolism from decreased cerebral blood flow in term neonates with hypoxic ischemic injury,25 elevations may be normal in preterm infants due to differences in metabolism.26

CONCLUSIONS

MRI is a non-invasive mode of neuroimaging that is superior to ultrasound and currently the best whole brain imaging tool available for the newborn. It has great potential for clinical use in characterizing the extent of preterm brain injury in neonates and predicting neurodevelopmental outcomes. In regards to advanced MRI modalities, additional research is needed to prove clinical utility, but holds promise. With the combination of conventional and advanced MR imaging techniques, we hope to be able to attain a more comprehensive view of the preterm brain – including both macrostructural and microstructural changes to better predict those at highest risk of impairment, as well as precisely define the type and extent of deficits likely to develop in the future and use the imaging tool to monitor effects of therapeutic interventions.

Acknowledgements

Modified from Kwong, Vassung, Ment, Hüppi et al Clinics in Perinatology

Tables reproduced with permission

References

1. Larroque B, Ancel PY, Marret S, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008;371:813. 2. Kidokoro H, Anderson PJ, Doyle LW, Neil JJ, Inder TE. High signal intensity on T2-weighted MR imaging at term-equivalent age in preterm infants does not predict 2-year neurodevelopmental outcomes. AJNR Am J Neuroradiol 2011;32:2005-10. 3. Maalouf EF, Duggan PJ, Rutherford MA, et al. Magnetic resonance imaging of the brain in a cohort of extremely preterm infants 8. JPediatr 1999;135:351. 4. Dyet LE, Kennea N, Counsell SJ, et al. Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment. Pediatrics 2006;118:536. 5. Huang H, Jeon T, Sedmak G, et al. Coupling Diffusion Imaging with Histological and Gene Expression Analysis to Examine the Dynamics of Cortical Areas across the Fetal Period of Human Brain Development. CerebCortex. 6. Setanen S, Haataja L, Parkkola R, Lind A, Lehtonen L. Predictive value of neonatal brain MRI on the neurodevelopmental outcome of preterm infants by 5 years of age. Acta Paediatr 2013;102:492-7. 7. Woodward LJ, Clark CA, Bora S, Inder TE. Neonatal white matter abnormalities an important predictor of neurocognitive outcome for very preterm children. PLoS One 2012;7:e51879. 8. Woodward LJ, Clark CA, Pritchard VE, Anderson PJ, Inder TE. Neonatal white matter abnormalities predict global executive function impairment in children born very preterm. Dev Neuropsychol 2011;36:22-41. 9. Volpe JJ. Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important. JChild Neurol 2009;24:1085. 10. Miller SP, Ferriero DM, Leonard C, et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. JPediatr 2005;147:609. 11. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. NEnglJMed 2006;355:685. 12. Inder TE, Wells SJ, Mogridge NB, Spencer C, Volpe JJ. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study 2. JPediatr 2003;143:171. 13. Kidokoro H, Neil JJ, Inder TE. New MR imaging assessment tool to define brain abnormalities in very preterm infants at term. AJNR Am J Neuroradiol 2013;34:2208-14. 14. Leuchter RH, Gui L, Poncet A, et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA 2014;312:817-24. 15. Dubois J, Benders M, Cachia A, et al. Mapping the early cortical folding process in the preterm newborn brain. Cereb Cortex 2008;18:1444-54. 16. Huppi PS, Maier SE, Peled S, et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res 1998;44:584-90. 17. Woodward LJ, Edgin JO, Thompson D, Inder TE. Object working memory deficits predicted by early brain injury and development in the preterm infant. Brain 2005;128:2578. 18. Peterson BS, Anderson AW, Ehrenkranz R, et al. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003;111:939. 19. Inder TE, Warfield SK, Wang H, Huppi PS, Volpe JJ. Abnormal cerebral structure is present at term in premature infants 4. Pediatrics 2005;115:286. 20. Boardman JP, Craven C, Valappil S, et al. A common neonatal image phenotype predicts adverse neurodevelopmental outcome in children born preterm. Neuroimage;52:409. 21. Kunz N, Zhang H, Vasung L, et al. Assessing white matter microstructure of the newborn with multi-shell diffusion MRI and biophysical compartment models. Neuroimage 2014;96:288-99. 22. Born P, Rostrup E, Larsson HB, Leth H, al e. Changing Pattern of visually induced fMRI response during human development. 1996; New York. p. 1860. 23. Seghier ML, Huppi PS. The role of functional magnetic resonance imaging in the study of brain development, injury, and recovery in the newborn. Semin Perinatol 2010;34:79-86. 24. Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn ResonMed 2002;48:949. 25. Miller SP, Newton N, Ferriero DM, et al. Predictors of 30-month outcome after perinatal depression: role of proton MRS and socioeconomic factors. PediatrRes 2002;52:71. 26. Leth H, Toft PB, Pryds O, Peitersen B, Lou HC, Henriksen O. Brain lactate in preterm and growth-retarded neonates. Acta Paediatr 1995;84:495. 27. Rutherford M, Srinivasan L, Dyet L, et al. Magnetic resonance imaging in perinatal brain injury: clinical presentation, lesions and outcome. PediatrRadiol 2006;36:582. 28. Beaulieu C, Plewes C, Paulson LA, et al. Imaging brain connectivity in children with diverse reading ability. Neuroimage 2005;25:1266. 29. Dudink J, Lequin M, van PC, et al. Fractional anisotropy in white matter tracts of very-low-birth-weight infants. PediatrRadiol 2007;37:1216. 30. Mukherjee P, McKinstry RC. Diffusion tensor imaging and tractography of human brain development. Neuroimaging ClinNAm 2006;16:19. 31. Wimberger DM, Roberts TP, Barkovich AJ, Prayer LM, Moseley ME, Kucharczyk J. Identification of "premyelination" by diffusion-weighted MRI. JComptrAssisted Tomography 1995;19:28. 32. Ment LR, Hirtz D, Huppi PS. Imaging biomarkers of outcome in the developing preterm brain. Lancet Neurol 2009;8:1042-55.

Figures

Table

Table

Table



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0000